NovoRapid (insulin aspart) - $2.3 Bn |Novo Nordisk 9.Jentadueto / Trajenta (linagliptine) -$1.8 Bn I Boehringer Ingelheim 10.Lantus (insulin glargine) - $1.7 Bn /Sanofi The diabetes treatment landscape is being reshaped by incretin-based therapies, reflecting a shift toward more effective, patient-friendly options
Under oxidative or nitrosative stress, GSH covalently binds to exposed cysteine thiols on enzymes, protecting them from irreversible oxidation and modulating their activity
acnes and suppressed the release of TNF-
Simultaneously, ferrous iron (Fe 2+ ) reacts with hydrogen peroxide (H 2 O 2 ) via the Fenton reaction to generate highly reactive hydroxyl radicals (OH), which further propagate lipid peroxidation
Starting dose: 2.5 mg once weekly for the first 4 weeks
Another option is therapy, where working with a physical therapist can enhance mobility, strength, and flexibility and reduce pain